A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVSV Vaccine in Patients With Ovarian Cancer After Surgery
PHASE1
This is a Phase I, single-arm, open-label, prospective, non-randomized, sin...
Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine in Older Adults Who Received a Primary Vaccination (3 or More Years Earlier) in Study MET49
PHASE3
Primary Objective:
To demonstrate sufficiency of the vaccine seroresponse ...
TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery
PHASE2
This phase II trial studies how well TPIV100 and sargramostim work in treat...